A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of 4-10 Oligometastatic Tumors (SABR-COMET 10) (NCT03721341)
SABR-COMET 10
This trial is No longer recruiting
Registration number NCT03721341
Program & service
This trial is being run with the Cancer service, and as part of the Radiation Oncology program.
Trial phase
Phase 3
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Associate Professor Sashendra Senthi
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR